DK1014948T3 - Lyofiliseret farmaceutisk præparat som er beregnet til at efterligne et lægemiddel på basis af proteiner eller polypeptider - Google Patents
Lyofiliseret farmaceutisk præparat som er beregnet til at efterligne et lægemiddel på basis af proteiner eller polypeptiderInfo
- Publication number
- DK1014948T3 DK1014948T3 DK98943975T DK98943975T DK1014948T3 DK 1014948 T3 DK1014948 T3 DK 1014948T3 DK 98943975 T DK98943975 T DK 98943975T DK 98943975 T DK98943975 T DK 98943975T DK 1014948 T3 DK1014948 T3 DK 1014948T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- proteins
- mimic
- polypeptides
- lyophilized pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9711626A FR2768341B1 (fr) | 1997-09-18 | 1997-09-18 | Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides |
| PCT/FR1998/001956 WO1999013866A1 (fr) | 1997-09-18 | 1998-09-14 | Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1014948T3 true DK1014948T3 (da) | 2007-09-24 |
Family
ID=9511216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98943975T DK1014948T3 (da) | 1997-09-18 | 1998-09-14 | Lyofiliseret farmaceutisk præparat som er beregnet til at efterligne et lægemiddel på basis af proteiner eller polypeptider |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6242423B1 (da) |
| EP (1) | EP1014948B1 (da) |
| AT (1) | ATE365542T1 (da) |
| CA (1) | CA2304021A1 (da) |
| CY (1) | CY1106769T1 (da) |
| DE (1) | DE69837997T2 (da) |
| DK (1) | DK1014948T3 (da) |
| ES (1) | ES2287980T3 (da) |
| FR (1) | FR2768341B1 (da) |
| PT (1) | PT1014948E (da) |
| WO (1) | WO1999013866A1 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2768341B1 (fr) * | 1997-09-18 | 2000-04-14 | Lab Francais Du Fractionnement | Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides |
| US6566575B1 (en) | 2000-02-15 | 2003-05-20 | 3M Innovative Properties Company | Patterned absorbent article for wound dressing |
| US6977323B1 (en) | 2000-02-17 | 2005-12-20 | 3M Innovative Properties Company | Foam-on-film medical articles |
| US6716186B1 (en) | 2000-08-16 | 2004-04-06 | 3M Innovative Properties Company | Curable adhesive splints and methods |
| US6903243B1 (en) | 2000-09-08 | 2005-06-07 | 3M Innovative Properties Company | Multi-layer absorbent wound dressing |
| US7005143B2 (en) | 2002-04-12 | 2006-02-28 | 3M Innovative Properties Company | Gel materials, medical articles, and methods |
| US7612248B2 (en) | 2002-12-19 | 2009-11-03 | 3M Innovative Properties Company | Absorbent medical articles |
| US20050070688A1 (en) | 2003-09-26 | 2005-03-31 | 3M Innovative Properties Company | Reactive hydrophilic oligomers |
| US7384984B2 (en) | 2003-12-10 | 2008-06-10 | 3M Innovative Properties Company | Reactive hydrophilic oligomers |
| US7074839B2 (en) * | 2004-03-01 | 2006-07-11 | 3M Innovative Properties Company | Crosslinkable hydrophilic materials from reactive oligomers having pendent photoinitiator groups |
| US7342047B2 (en) | 2004-03-02 | 2008-03-11 | 3M Innovative Properties Company | Crosslinkable hydrophilic materials from reactive oligomers having pendent unsaturated groups |
| US8609131B2 (en) | 2005-01-25 | 2013-12-17 | 3M Innovative Properties Company | Absorbent dressing comprising hydrophilic polymer prepared via Michael reaction |
| US7335690B2 (en) | 2005-01-25 | 2008-02-26 | 3M Innovative Properties Company | Crosslinkable hydrophilic materials from polymers having pendent Michael donor groups |
| US7981949B2 (en) | 2006-05-23 | 2011-07-19 | 3M Innovative Properties Company | Curable hydrophilic compositions |
| WO2011082196A2 (en) | 2009-12-30 | 2011-07-07 | Baxter International Inc. | Rapid reconstitution for lyophilized-pharmaceutical suspensions |
| WO2023183542A2 (en) * | 2022-03-25 | 2023-09-28 | Amgen Inc. | Artificial lyophilized product samples for automated visual inspection systems |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5151511A (en) * | 1974-10-25 | 1976-05-07 | Tooru Tatsuhara | Aminosanseizai no anteikaho |
| ATE24964T1 (de) * | 1981-12-11 | 1987-01-15 | Wyeth John & Brother Ltd | Verfahren zur herstellung von festen formgegenstaenden. |
| IL78930A0 (en) * | 1985-07-29 | 1986-09-30 | Abbott Lab | Lyophilized emulsion compositions for parenteral administration |
| FR2719479B1 (fr) * | 1994-05-04 | 1996-07-26 | Sanofi Elf | Formulation stable lyophilisée comprenant une protéine: kit de dosage. |
| FR2751177B1 (fr) * | 1996-07-17 | 1998-08-28 | Morelle Jean | Compositions exemptes de proteines et de peptides obtenues a partir de toutes proteines animales, destinees a l'alimentation animale et humaine, ainsi qu'a l'usage cosmetique pharmaceutique et agricole |
| FR2768341B1 (fr) * | 1997-09-18 | 2000-04-14 | Lab Francais Du Fractionnement | Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides |
-
1997
- 1997-09-18 FR FR9711626A patent/FR2768341B1/fr not_active Expired - Fee Related
-
1998
- 1998-09-14 EP EP98943975A patent/EP1014948B1/fr not_active Expired - Lifetime
- 1998-09-14 DE DE69837997T patent/DE69837997T2/de not_active Expired - Lifetime
- 1998-09-14 DK DK98943975T patent/DK1014948T3/da active
- 1998-09-14 US US09/508,831 patent/US6242423B1/en not_active Expired - Fee Related
- 1998-09-14 CA CA002304021A patent/CA2304021A1/fr not_active Abandoned
- 1998-09-14 PT PT98943975T patent/PT1014948E/pt unknown
- 1998-09-14 WO PCT/FR1998/001956 patent/WO1999013866A1/fr active IP Right Grant
- 1998-09-14 AT AT98943975T patent/ATE365542T1/de active
- 1998-09-14 ES ES98943975T patent/ES2287980T3/es not_active Expired - Lifetime
-
2007
- 2007-07-30 CY CY20071101005T patent/CY1106769T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1106769T1 (el) | 2012-05-23 |
| EP1014948B1 (fr) | 2007-06-27 |
| ATE365542T1 (de) | 2007-07-15 |
| FR2768341A1 (fr) | 1999-03-19 |
| DE69837997D1 (de) | 2007-08-09 |
| EP1014948A1 (fr) | 2000-07-05 |
| CA2304021A1 (fr) | 1999-03-25 |
| DE69837997T2 (de) | 2008-02-28 |
| FR2768341B1 (fr) | 2000-04-14 |
| ES2287980T3 (es) | 2007-12-16 |
| WO1999013866A1 (fr) | 1999-03-25 |
| PT1014948E (pt) | 2007-07-18 |
| US6242423B1 (en) | 2001-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1014948T3 (da) | Lyofiliseret farmaceutisk præparat som er beregnet til at efterligne et lægemiddel på basis af proteiner eller polypeptider | |
| NO965012L (no) | Farmasöytisk preparat som omfatter glukagon | |
| DE69428040D1 (de) | Orale darreichungsform | |
| KR920019371A (ko) | 안정화된 인자 ⅷ 제제 | |
| DK1137400T3 (da) | Præparater indeholdende et peptid og polymælkesyre-glycolsyre egnet til fremstilling af subkutane implantater med en forlænget frigivelsesperiode | |
| ATE214614T1 (de) | Ein wachstumshormon und isoleucin enthaltende pharmazeutische formulierung | |
| DK1079849T3 (da) | Anvendelse af HMG-proteiner til fremstilling af lægemidler med cytotoksisk virkning | |
| DE3866045D1 (de) | Arzneimittel zur behandlung von uraemie. | |
| ES2196187T3 (es) | Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen. | |
| KR970706840A (ko) | 성장호르몬 및 발린으로 이루어진 약학적 조성물(a pharmaceutical formulation comprising a growth hormone and valine) | |
| BR9809103A (pt) | Forma farmacêutica estável de administração para peptìdeos, proteìnas e ácidos nucléicos | |
| ES2059312T3 (es) | Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion. | |
| DK0707473T3 (da) | Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler | |
| AR057639A2 (es) | Analogos del peptido 1- similar al glucagon uso de los mismos par ala manufactura de un medicamento y composiciones farmaceuticas que los contienen | |
| KR910700259A (ko) | T-세포 인지성 펩티드 변형에 의해 면역반응에 영향을 주는 방법 | |
| NO942323L (no) | Soyaprotein eller hydrolysater i farmasöytiske preparater for beskyttelse av bioaktive peptider mot enzymatisk inaktivering | |
| AR012996A1 (es) | Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador. | |
| DE69525757T2 (de) | Ein wachstumshormon und leucin enthaltende pharmazeutische formulierung | |
| NO980103L (no) | Stabilisert farmasöytisk preparat som omfatter et veksthormon og et peptid omfattende minst én basisk aminosyrerest og minst én sur aminosyrerest | |
| AU9221898A (en) | Pharmaceutical coating composition and method of use | |
| SE9904132D0 (sv) | Pharmaceutical composition for treatment of diarrhea | |
| KR920700224A (ko) | 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제 | |
| MX9604539A (es) | Aminoacidos modificados para la distribucion de farmaco. |